Extradigestive manifestations of Helicobacter pylori gastric infection

A Gasbarrini1, F Franceschi, A Armuzzi

  • 1Department of Medical Pathology, Catholic University of Rome, Rome, Italy.

Gut
|August 24, 1999
PubMed

Insights

Recent studies link Helicobacter pylori infection to extradigestive issues, including cardiovascular and autoimmune diseases. New findings suggest Helicobacter species in bile may impact biliary tract disease diagnosis and treatment.

Area of Science:

  • Microbiology and Immunology
  • Gastroenterology
  • Cardiovascular Medicine

Background:

  • Emerging research explores the link between Helicobacter pylori (H. pylori) infection and extradigestive diseases.
  • Studies indicate a higher prevalence of H. pylori in patients with ischemic heart disease.
  • Growing evidence suggests an association between H. pylori and certain autoimmune conditions.

Purpose of the Study:

  • To review recent findings on the association between H. pylori infection and extradigestive pathologies.
  • To highlight the potential role of H. pylori in cardiovascular and autoimmune diseases.
  • To discuss the implications of detecting Helicobacter species in human bile for biliary tract disease management.

Main Methods:

  • Literature review of recent studies on H. pylori and extradigestive diseases.
  • Analysis of epidemiological data regarding H. pylori prevalence in specific patient groups.
  • Review of microbiological studies detecting Helicobacter species in human bile.

Main Results:

  • Several studies confirm a correlation between H. pylori infection and various extradigestive conditions.
  • A notable association exists between H. pylori and ischemic heart disease.
  • Preliminary evidence suggests a link between H. pylori and autoimmune disorders.
  • Detection of various Helicobacter species in human bile has been reported in recent research.

Conclusions:

  • H. pylori infection is increasingly recognized for its role in extradigestive diseases.
  • The presence of Helicobacter species in bile warrants further investigation and may alter clinical practice for biliary tract diseases.

Related Concept Videos

Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...